Stock 300406 BEIJING STRONG BIOTECHNOLOGIES,INC.
Add to a list
To use this feature you must be a member
Log inSign up

Ratings Beijing Strong Biotechnologies,Inc.

Equities

300406

CNE100001Y26

End-of-day quote Shenzhen S.E.
Other stock markets
 06:00:00 2024-05-27 pm EDT 		5-day change 1st Jan Change
16.91 CNY -1.57% Intraday chart for Beijing Strong Biotechnologies,Inc. -2.03% -11.47%
Apr. 28 Beijing Strong Biotechnologies,Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Apr. 25 Beijing Strong Biotechnologies,Inc. Announces Final Cash Dividend (Tax Included) (A Shares) for 2023, Payable on 07 May 2024 CI

Strengths

  • Its core activity has a significant growth potential and sales are expected to surge, according to Standard & Poor's' forecast. Indeed, those may increase by 62% by 2026.
  • Margins returned by the company are among the highest on the stock exchange list. Its core activity clears big profits.
  • Analysts covering this company mostly recommend stock overweighting or purchase.

Weaknesses

  • For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
  • The company's sales previsions for the coming years have been revised downwards, which foreshadows another slowdown in business.
  • Financial statements have repeatedly disappointed market stakeholders. Most often, they were below expectations.

Ratings chart - Surperformance

Sector: Medical Equipment, Supplies & Distribution

1st Jan change Capi. Investor Rating ESG Refinitiv
BEIJING STRONG BIOTECHNOLOGIES,INC. Stock Beijing Strong Biotechnologies,Inc.
-11.47% 1.39B -
BIOMÉRIEUX Stock bioMérieux
-6.41% 12.2B
B+
SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO., LTD. Stock Shenzhen New Industries Biomedical Engineering Co., Ltd.
-4.07% 8.22B
B-
DIASORIN S.P.A. Stock DiaSorin S.p.A.
+5.77% 5.72B
B
LANTHEUS HOLDINGS, INC. Stock Lantheus Holdings, Inc.
+28.13% 5.42B
C
10X GENOMICS, INC. Stock 10x Genomics, Inc.
-59.44% 2.7B
D+
ANDON HEALTH CO., LTD. Stock Andon Health Co., Ltd.
+8.04% 2.63B - -
VITROLIFE AB Stock Vitrolife AB
-6.47% 2.38B
B-
MYRIAD GENETICS, INC. Stock Myriad Genetics, Inc.
+21.84% 2.1B
C
GUANGZHOU WONDFO BIOTECH CO.,LTD Stock Guangzhou Wondfo Biotech Co.,Ltd
-8.15% 1.81B
D+
Investor Rating
Trading Rating
-
ESG Refinitiv
-

Financials

Sales growth
Earnings Growth
EBITDA / Sales
-
Profitability
Finances
-

Valuation

P/E ratio
EV / Sales
-
Price to Book
Price to Free Cash Flow
-
Yield
-

Momentum

1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision

Consensus

Analyst Opinion
Potential Price Target
-
4m Target Price Revision
-
4m Revision of opinion
-
12m Revision of opinion

Business Predictability

Analyst Coverage
Divergence of Estimates
-
Divergence of analysts' opinions
-
Divergence of Target Price
-
Earnings quality

Technical analysis

ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
  1. Stock Market
  2. Equities
  3. 300406 Stock
  4. Ratings Beijing Strong Biotechnologies,Inc.